EPISODE · Jan 18, 2025 · 7 MIN
Part 1: 2024 Hatch-Waxman Year in Review
from Womble Perspectives · host Womble Bond Dickinson
In today's episode, first in a two part series, we’re going to unpack the year in review for the Hatch-Waxman Act—a critical framework in the pharmaceutical industry that continues to shape the dynamics between brand-name drugmakers and generics. 2024 has been a fascinating year, with significant trends and legal shifts that have implications for innovation, accessibility, and regulatory strategy. Whether you’re a legal professional, a business leader in pharma, or simply interested in the interplay between patents and healthcare, this episode will give you key insights into what shaped the legal landscape this year. Read the full article2024 Hatch-Waxman Year in ReviewAbout the authorsBen BourkeAlexander P. Wharton
What this episode covers
In today's episode, first in a two part series, we’re going to unpack the year in review for the Hatch-Waxman Act—a critical framework in the pharmaceutical industry that continues to shape the dynamics between brand-name drugmakers and generics. 2024 has been a fascinating year, with significant trends and legal shifts that have implications for innovation, accessibility, and regulatory strategy. Whether you’re a legal professional, a business leader in pharma, or simply interested in...
NOW PLAYING
Part 1: 2024 Hatch-Waxman Year in Review
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m